American Journal of Ophthalmology
Volume 142, Issue 3 , Pages 441-447.e2 , September 2006

Risk Factors for Photodynamic Therapy of Predominantly Classic Choroidal Neovascularization in Age-related Macular Degeneration

  • Igor Kaiserman, MD, MSc, MHA

      Affiliations

    • Department of Ophthalmology, Barzilai Medical Center, Ashkelon, Israel
    • Corresponding Author InformationInquiries to Igor Kaiserman, MD, MSc, MHA, Department of Ophthalmology, Barzilai Medical Center, 78306 Ashkelon, Israel
    • ,
  • Nadia Kaiserman, BSc

      Affiliations

    • Department of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel
    • ,
  • Asher Elhayany, MD

      Affiliations

    • Department of Family Medicine, Clalit Health Services, Rehovot, Israel
    • ,
  • Shlomo Vinker, MD

      Affiliations

    • Department of Family Medicine, Clalit Health Services, Rehovot, Israel
    • Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

,Accepted 11 April 2006.

References 

  1. Leibowitz HM , Krueger DE , Maunder LR , et al.   The Framingham Eye Study monograph (an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975) . Surv Ophthalmol . 1980;24:335–610
  2. Klein BE , Klein R . Cataracts and macular degeneration in older Americans . Arch Ophthalmol . 1982;100:571–573
  3. Klein R , Klein BE , Jensen SC , Meuer SM . The five-year incidence and progression of age-related maculopathy (The Beaver Dam Eye Study) . Ophthalmology . 1997;104:7–21
  4. Klein R , Klein BE , Linton KL . Prevalence of age-related maculopathy. The Beaver Dam Eye Study . Ophthalmology . 1992;99:933–943
  5. Klein R , Wang Q , Klein BE , et al.   The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity . Invest Ophthalmol Vis Sci . 1995;36:182–191
  6. Treatment-of-age-related-macular-degeneration-with-photodynamic-therapy -(TAP)-Study-Group . Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin (one-year results of 2 randomized clinical trials-TAP report) . Arch Ophthalmol . 1999;117:1329–1345
  7. Smith W , Assink J , Klein R , et al.   Risk factors for age-related macular degeneration (Pooled findings from three continents) . Ophthalmology . 2001;108:697–704
  8. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report No. 3 . Ophthalmology . 2000;107:2224–2232
  9. Miyazaki M , Kiyohara Y , Yoshida A , et al.   The five-year incidence and risk factors for age-related maculopathy in a general Japanese population (the Hisayama study) . Invest Ophthalmol Vis Sci . 2005;46:1907–1910
  10. McCarty CA , Mukesh BN , Fu CL , et al.   Risk factors for age-related maculopathy (the Visual Impairment Project) . Arch Ophthalmol . 2001;119:1455–1462
  11. Santos LP , Diniz JR , Leao AC , Sena MF . Degeneracao macular relacionada a idade (prevalencia e fatores de risco em dois centros oftalmologicos de referencia em Pernambuco) . [Age-related macular degeneration: analysis in two ophthalmological centers in Pernambuco-Brazil] Arq Bras Oftalmol . 2005;68:229–233
  12. Buch H , Vinding T , la Cour M , et al.   Risk factors for age-related maculopathy in a 14-year follow-up study (the Copenhagen City Eye Study) . Acta Ophthalmol Scand . 2005;83:409–418
  13. Clemons TE , Milton RC , Klein R , et al.   Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS Report No. 19 . Ophthalmology . 2005;112:533–539
  14. Evans JR , Fletcher AE , Wormald RP . 28,000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking . Br J Ophthalmol . 2005;89:550–553
  15. Tomany SC , Wang JJ , van Leeuwen R , et al.   Risk factors for incident age-related macular degeneration (pooled findings from three continents) . Ophthalmology . 2004;111:1280–1287
  16. van Leeuwen R , Ikram MK , Vingerling JR , et al.   Blood pressure, atherosclerosis, and the incidence of age-related maculopathy (the Rotterdam Study) . Invest Ophthalmol Vis Sci . 2003;44:3771–3777
  17. Chaine G , Hullo A , Sahel J , et al.  France-DMLA Study Group   Case-control study of the risk factors for age-related macular degeneration . Br J Ophthalmol . 1998;82:996–1002
  18. Hyman L , Schachat AP , He Q , Leske MC  Age-Related Macular Degeneration Risk Factors Study Group . Hypertension, cardiovascular disease, and age-related macular degeneration . Arch Ophthalmol . 2000;118:351–358
  19. Wachter A , Sun Y , Dasch B , et al.   Munsteraner Altern- und Retinastudie (MARS). Zusammenhang zwischen Risikofaktoren der Arteriosklerose und der altersabhangiger Makuladegeneration. [Munster age- and retina study (MARS). Association between risk factors for arteriosclerosis and age-related macular degeneration] . Ophthalmologe . 2004;101:50–53
  20. Belda Sanchis JI , Quijada Gonzalez A , Munoz Ruiz G , et al.   Los lipidos sericos, factor de riesgo de la degeneracion macular asociada a la edad? [Are blood lipids a risk factor for age-related macular degeneration?] . Arch Soc Esp Oftalmol . 2001;76:13–17
  21. Schaumberg DA , Christen WG , Hankinson SE , Glynn RJ . Body mass index and the incidence of visually significant age-related maculopathy in men . Arch Ophthalmol . 2001;119:1259–1265
  22. Klein BE , Klein R , Lee KE , Jensen SC . Measures of obesity and age-related eye diseases . Ophthalmic Epidemiol . 2001;8:251–262
  23. Moeini HA , Masoudpour H , Ghanbari H . A study of the relation between body mass index and the incidence of age-related macular degeneration . Br J Ophthalmol . 2005;89:964–966
  24. Delcourt C , Michel F , Colvez A , et al.   Associations of cardiovascular disease and its risk factors with age-related macular degeneration (the POLA Study) . Ophthalmic Epidemiol . 2001;8:237–249
  25. Rennert G , Peterburg Y . Prevalence of selected chronic diseases in Israel . Isr Med Assoc J . 2001;3:404–408
  26. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure . Arch Intern Med . 1997;157:2413–2446
  27. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (the JNC 7 report) . JAMA . 2003;289:2560–2572
  28. Conroy RM , Pyorala K , Fitzgerald AP , et al.   Estimation of ten-year risk of fatal cardiovascular disease in Europe (the SCORE project) . Eur Heart J . 2003;24:987–1003
  29. Hyman LG , Lilienfeld AM , Ferris FL , Fine SL . Senile macular degeneration (a case-control study) . Am J Epidemiol . 1983;118:213–227
  30. Haddad WM , Coscas G , Soubrane G . Eligibility for treatment and angiographic features at the early stage of exudative age-related macular degeneration . Br J Ophthalmol . 2002;86:663–669
  31. Bressler NM . Age-related macular degeneration. New hope for a common problem comes from photodynamic therapy . BMJ . 2000;321:1425–1427
  32. Javitt JC , Zhou Z , Maguire MG , et al.   Incidence of exudative age-related macular degeneration among elderly Americans . Ophthalmology . 2003;110:1534–1539
  33. Voutilainen Kaunisto RM , Terasvirta ME , Uusitupa MI , Niskanen LK . Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects (a 10-year follow-up on evolution, risk factors, and prognostic significance) . Diabetes Care . 2000;23:1672–1678
  34. Mitchell P , Wang JJ . Diabetes, fasting blood glucose and age-related maculopathy (the Blue Mountains Eye Study) . Aust N Z J Ophthalmol . 1999;27:197–199
  35. Klein R , Klein BE , Jensen SC , Moss SE . The relation of socioeconomic factors to the incidence of early age-related maculopathy (the Beaver Dam Eye Study) . Am J Ophthalmol . 2001;132:128–131
  36. Walter-Ginzburg A , Guralnik JM , Blumstein T , et al.   Assistance with personal care activities among the old-old in Israel (a national epidemiological study) . J Am Geriatr Soc . 2001;49:1176–1184
  37. Yoshida A , Yoshida M , Yoshida S , et al.   Familial cases with age-related macular degeneration . Jpn J Ophthalmol . 2000;44:290–295
  38. Smith W , Mitchell P . Family history and age-related maculopathy (the Blue Mountains Eye Study) . Aust N Z J Ophthalmol . 1998;26:203–206
  39. Grizzard SW , Arnett D , Haag SL . Twin study of age-related macular degeneration . Ophthalmic Epidemiol . 2003;10:315–322
  40. Klaver CC , Kliffen M , van Duijn CM , et al.   Genetic association of apolipoprotein E with age-related macular degeneration . Am J Hum Genet . 1998;63:200–206
  41. Schultz DW , Weleber RG , Lawrence G , et al.   HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease (review and perspective) . Ophthalmic Genet . 2005;26:101–105
  42. van Leeuwen R , Klaver CC , Vingerling JR , et al.   Cholesterol and age-related macular degeneration (is there a link?) . Am J Ophthalmol . 2004;137:750–752
  43. Klein R , Klein BE , Knudtson MD , et al.   Prevalence of age-related macular degeneration in four racial/ethnic groups in the multi-ethnic study of atherosclerosis . Ophthalmology . 2006;113:373–380

PII: S0002-9394(06)00504-6

doi: 10.1016/j.ajo.2006.04.031

American Journal of Ophthalmology
Volume 142, Issue 3 , Pages 441-447.e2 , September 2006

Article Tools

* Image Usage & Resolution